Other secondary thrombocytopenia. D69.59 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes. The 2019 edition of ICD-10-CM D69.59 became effective on October 1, 2018.
Oct 01, 2021 · Thrombocytosis, unspecified. 2016 2017 2018 2019 2020 2021 2022 Billable/Specific Code. D75.839 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes. The 2022 edition of ICD-10-CM D75.839 became effective on October 1, 2021.
Oct 01, 2021 · Thrombocytosis. 2016 2017 2018 2019 2020 2021 2022 Non-Billable/Non-Specific Code. D75.83 should not be used for reimbursement purposes as there are multiple codes below it that contain a greater level of detail. The 2022 edition of ICD-10-CM D75.83 became effective on October 1, 2021.
Oct 01, 2021 · Other secondary thrombocytopenia. 2016 2017 2018 2019 2020 2021 2022 Billable/Specific Code. D69.59 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes. The 2022 edition of ICD-10-CM D69.59 became effective on October 1, 2021.
secondary thrombocytosis ( D75.838) thrombocythemia NOS ( D75.839) thrombocytosis NOS ( D75.839) idiopathic D47.3. ICD-10-CM Diagnosis Code D47.3. Essential (hemorrhagic) thrombocythemia. 2016 2017 2018 2019 2020 2021 2022 Billable/Specific Code. Applicable To. Essential thrombocytosis.
A type 2 excludes note represents "not included here". A type 2 excludes note indicates that the condition excluded is not part of the condition it is excluded from but a patient may have both conditions at the same time. When a type 2 excludes note appears under a code it is acceptable to use both the code ( D75.83) and the excluded code together.
D50-D89 Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism
D75.83 should not be used for reimbursement purposes as there are multiple codes below it that contain a greater level of detail.
The 2022 edition of ICD-10-CM D69.59 became effective on October 1, 2021.
D50-D89 Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism
D50-D89 Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism
A code also note instructs that 2 codes may be required to fully describe a condition but the sequencing of the two codes is discretionary, depending on the severity of the conditions and the reason for the encounter.
The 2022 edition of ICD-10-CM D69.5 became effective on October 1, 2021.
D50-D89 Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism
A type 1 excludes note is a pure excludes. It means "not coded here". A type 1 excludes note indicates that the code excluded should never be used at the same time as D69.5. A type 1 excludes note is for used for when two conditions cannot occur together, such as a congenital form versus an acquired form of the same condition.
Approximate Synonyms. Erythrocytosis. Erythrocytosis secondary to tobacco use. Erythrocytosis secondary to tobacco use or abuse. Polycythemia, secondary. Clinical Information. An abnormal increase of the red blood cell in the circulating blood. An increase in the total red cell mass of the blood.
The 2022 edition of ICD-10-CM D75.1 became effective on October 1, 2021.
D50-D89 Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism